Primary angioplasty

NEW YORK, June 14 (Praxis Press) Rapid reperfusion after acute myocardial infarction (MI) using thrombolytic therapy reduces mortality, but whether time to primary angioplasty is also related to mortality is unclear. Investigators examined 27,080 patients with acute MI associated with ST-segment elevation or left bundle-branch block who were treated with angioplasty (see paper). Cannon and colleagues found that the odds of in-hospital mortality increased from 41% to 62% when the time to primary


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, June 14 (Praxis Press) Rapid reperfusion after acute myocardial infarction (MI) using thrombolytic therapy reduces mortality, but whether time to primary angioplasty is also related to mortality is unclear. Investigators examined 27,080 patients with acute MI associated with ST-segment elevation or left bundle-branch block who were treated with angioplasty (see paper). Cannon and colleagues found that the odds of in-hospital mortality increased from 41% to 62% when the time to primary angioplasty was more than 2 hours after the patient had arrived at the hospital. Increasing delay from symptom onset to primary angioplasty, however, was not associated with a significant increase in in-hospital mortality. Minimizing the time from patient arrival to primary angioplasty reduces patient mortality.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours